Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
210.30
-0.10 (-0.05%)
At close: May 6, 2026
Market Cap186.51B -4.5%
Revenue (ttm)83.53B +10.1%
Net Income25.86B +10.0%
EPS29.18 +10.0%
Shares Out886.45M
PE Ratio7.21
Forward PE6.31
Dividend12.00 (5.70%)
Ex-Dividend DateNov 17, 2025
Volume266,301
Average Volume228,990
Openn/a
Previous Close210.40
Day's Range210.00 - 211.10
52-Week Range198.00 - 236.00
Beta0.10
RSI41.03
Earnings DateApr 29, 2026

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 15,937
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In fiscal year 2025, DSE:SQURPHARMA's revenue was 76.29 billion, an increase of 8.83% compared to the previous year's 70.10 billion. Earnings were 23.97 billion, an increase of 14.54%.

Financial Statements